1. Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study. Issue 1 (1st November 2018) Authors: Chen, Qiuyan; Tang, Linquan; Liu, Na; Han, Feng; Guo, Ling; Guo, Shanshan; Wang, Jianwei; Liu, Huai; Ye, Yanfang; Zhang, Lu; Liu, Liting; Wang, Pan; Li, Yingqin; He, Qingmei; Yang, Xiaoqun; Tang, Qingnan; Li, Yang; Liang, YuJing; Sun, XueSong; Xie, Chuanmiao Journal: Cancer communications Issue: Volume 38:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M6A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression. Issue 12 (December 2018) Authors: Zhang, Panpan; He, Qiuping; Lei, Yuan; Li, Yingqin; Wen, Xin; Hong, Mengzhi; Zhang, Jian; Ren, Xianyue; Wang, Yaqin; Yang, Xiaojing; He, Qingmei; Ma, Jun; Liu, Na Journal: Cell death and disease Issue: Volume 9:Issue 12(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. N6‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation. Issue 36 (30th October 2022) Authors: Zhao, Yin; Huang, Shengyan; Tan, Xirong; Long, Liufen; He, Qingmei; Liang, Xiaoyu; Bai, Jiewen; Li, Qingjie; Lin, Jiayi; Li, Yingqin; Liu, Na; Ma, Jun; Chen, Yupei Journal: Advanced science Issue: Volume 9:Issue 36(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗